SABCS Logo

December 10-13, 2024

Henry B. Gonzalez Convention Center

SABCS Logo
MENUMENU
  • Home
  • News
    • SABCS Snippets
    • Monday, Dec 16
    • Saturday, Dec 14
    • Friday, Dec 13
    • Thursday, Dec 12
    • Wednesday, Dec 11
    • Tuesday, Dec 10
    • Monday, Dec. 9
    • Presenter Profiles
    • Archives
      • 2024
      • 2023
      • 2022
      • 2021
      • 2020
  • Publications
    • Takeaways
    • Preview and Meeting Magazines
  • Featured Industry Events
    • Satellite Educational Symposia
    • Product Theaters
  • Get News Updates
  • SABCS.org
SABCS Logo
SABCS Logo
MENUMENU
  • Home
  • News
    • SABCS Snippets
    • Monday, Dec 16
    • Saturday, Dec 14
    • Friday, Dec 13
    • Thursday, Dec 12
    • Wednesday, Dec 11
    • Tuesday, Dec 10
    • Monday, Dec. 9
    • Presenter Profiles
    • Archives
      • 2024
      • 2023
      • 2022
      • 2021
      • 2020
  • Publications
    • Takeaways
    • Preview and Meeting Magazines
  • Featured Industry Events
    • Satellite Educational Symposia
    • Product Theaters
  • Get News Updates
  • SABCS.org
SABCS Logo
MENUMENU
  • Home
  • News
    • SABCS Snippets
    • Monday, Dec 16
    • Saturday, Dec 14
    • Friday, Dec 13
    • Thursday, Dec 12
    • Wednesday, Dec 11
    • Tuesday, Dec 10
    • Monday, Dec. 9
    • Presenter Profiles
    • Archives
      • 2024
      • 2023
      • 2022
      • 2021
      • 2020
  • Publications
    • Takeaways
    • Preview and Meeting Magazines
  • Featured Industry Events
    • Satellite Educational Symposia
    • Product Theaters
  • Get News Updates
  • SABCS.org

The latest news updates from the 2024 Symposium

  • Home
  • News
    • SABCS Snippets
    • Monday, Dec 16
    • Saturday, Dec 14
    • Friday, Dec 13
    • Thursday, Dec 12
    • Wednesday, Dec 11
    • Tuesday, Dec 10
    • Monday, Dec. 9
    • Presenter Profiles
    • Archives
      • 2024
      • 2023
      • 2022
      • 2021
      • 2020
  • Publications
    • Takeaways Magazine
    • Preview and Meeting Magazines
  • Featured Industry Events
    • Satellite Educational Symposia
    • Product Theaters
  • Featured Exhibitors
  • Photo Gallery

  • Final day of SABCS 20 features cutting-edge research, a lively debate, and the ‘Year in Review’

    Final day of SABCS 20 features cutting-edge research, a lively debate, and the ‘Year in Review’

    December 11, 2020

    Today is the final day of SABCS 20, but just in case you missed something, it’s not your final chance to view all of the great science presented this week. SABCS registrants will have exclusive on-demand access to SABCS 20 programs until March 13, 2021.

    Read More: Final day of SABCS 20 features cutting-edge research, a lively debate, and the ‘Year in Review’

  • Mini-Symposium explores multiple approaches to breast cancer prevention

    Mini-Symposium explores multiple approaches to breast cancer prevention

    December 11, 2020

    Just as no single breast cancer treatment is appropriate for all patients, no single prevention strategy is appropriate for all. Prophylactic mastectomy is highly effective in preventing breast cancer but is not often acceptable.

    Read More: Mini-Symposium explores multiple approaches to breast cancer prevention

  • Research providing new insights into mutagenesis in breast cancer

    Research providing new insights into mutagenesis in breast cancer

    December 11, 2020

    A normal breast cell in an 80-year-old woman has accumulated about 1,000 mutations while a breast cancer cell has about 5,000 mutations. It is not clear what factors might trigger the more rapid accumulations of mutations that are seen in tumor cells.

    Read More: Research providing new insights into mutagenesis in breast cancer

  • Educational Session explores advances in treating ER positive breast cancer

    Educational Session explores advances in treating ER positive breast cancer

    December 11, 2020

    One of the enduring problems in treating ER+ breast cancer is its persistent tendency to recur. HER+ and triple negative breast cancers usually recur within the first few years after treatment, but ER+ cancers have a steady rate of relapse over decades.

    Read More: Educational Session explores advances in treating ER positive breast cancer

  • Good clinical outcomes only a part of breast cancer recovery

    Good clinical outcomes only a part of breast cancer recovery

    December 11, 2020

    Recovering from breast cancer means more than good clinical outcomes. The overarching goal is good quality of life, which means balancing clinical outcomes with treatment toxicities while preserving a positive body image, good sexual health and, for patients who want it, the opportunity for biological children.

    Read More: Good clinical outcomes only a part of breast cancer recovery

  • Postmenopausal women with early-stage breast cancer and low recurrence score could skip adjuvant chemotherapy

    Postmenopausal women with early-stage breast cancer and low recurrence score could skip adjuvant chemotherapy

    December 11, 2020

    After a median follow-up of 5.1 years, among women with lymph node-positive early-stage breast cancer and a recurrence score of 25 or lower who received adjuvant endocrine therapy with or without chemotherapy, postmenopausal patients had no added benefit from chemotherapy.

    Read More: Postmenopausal women with early-stage breast cancer and low recurrence score could skip adjuvant chemotherapy

  • Under-recognition of symptoms may be common in patients with breast cancer receiving radiotherapy

    Under-recognition of symptoms may be common in patients with breast cancer receiving radiotherapy

    December 11, 2020

    Among patients with breast cancer treated with radiotherapy, under-recognition of symptoms was common in reports of pain, pruritus, edema, and fatigue, with younger patients and Black patients having significantly increased odds of symptom under-recognition.

    Read More: Under-recognition of symptoms may be common in patients with breast cancer receiving radiotherapy

  • Women who undergo mastectomy and reconstructive surgery may be at risk of becoming persistent drug users

    Women who undergo mastectomy and reconstructive surgery may be at risk of becoming persistent drug users

    December 11, 2020

    Women who receive mastectomy and reconstructive surgery as part of breast cancer treatment may face the risk of developing persistent use of opioids and sedative-hypnotic drugs.

    Read More: Women who undergo mastectomy and reconstructive surgery may be at risk of becoming persistent drug users

  • Session evaluations, CME and Certificates of Attendance are available on the SABCS app

    Session evaluations, CME and Certificates of Attendance are available on the SABCS app

    December 11, 2020

    To access the 2020 SABCS app sponsored by AstraZeneca, please search “San Antonio Breast Cancer Symposium” in the appropriate store (Google Play for Android, Apple for iOS) and download the app.

    Read More: Session evaluations, CME and Certificates of Attendance are available on the SABCS app

© 2025 SABCS. All Rights Reserved.
Powered By TriStar Event Media, LLC.
Privacy Policy

SABCS Logo

7979 Wurzbach Road, MC 8224
San Antonio, Texas 78229 USA

Telephone: 210-450-1550
sabcs.org

Get updates from SABCS Meeting News

Subscribe below to get email updates from SABCSMeetingNews.org